"Amici Clinical Research is the premier independent vaccine and drug study center in Central New Jersey specializing in studying investigative treatments for COVID-19, fatty liver, high cholesterol, migraine, diabetes, hypertension, pain and low testosterone. Our patients come first in everything we do. We are dedicated to discovery and committed to care."

During the past decade, Amici Clinical Research conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 9 clinical trials were completed, i.e. on average, 47.4% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 7 clinical trials were completed. i.e. 58.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Amici Clinical Research" #1 sponsor was "Pfizer" with 6 trials, followed by "BioNTech SE" with 5 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Avid Radiopharmaceuticals" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Amici Clinical Research" #1 collaborator was "Pfizer" with 4 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator and "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Amici Clinical Research" are "COVID-19" (5 trials), "SARS-CoV-2 Infection" (4 trials), "Alzheimer Disease" (2 trials), "Cardiovascular Disease" (2 trials) and "Clostridium Difficile Associated Disease" (2 trials). Many other conditions were trialed in "Amici Clinical Research" in a lesser frequency.

Most popular intervention types in "Amici Clinical Research" are "Drug" (12 trials), "Biological" (9 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "BNT162b2" (5 trials), "Clostridium difficile vaccine" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Apixaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Amici Clinical Research" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Amici Clinical Research". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Amici Clinical Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Amici Clinical Research, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".